Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer
Completed · Phase 1/Phase 2
Conditions studied: Colorectal Cancer, Kidney Cancer
In brief
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of biological therapy combined with chemotherapy in treating patients who have metastatic kidney cancer or colorectal cancer.
Key facts
- Study ID
- NCT00030342
- Run by
- St. Luke's Medical Center
- People needed
- 60
- Starts
- 2001-11-01
- Expected to finish
- 2008-01-01
- Last updated by the study team
- 2013-06-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.